You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pexidartinib

Showing 1 - 14 of 14
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tenosynovial Giant Cell Tumor Trial in Japan (Pexidartinib)

Recruiting
  • Tenosynovial Giant Cell Tumor
  • Pexidartinib
  • Aichi, Japan
  • +5 more
Jun 29, 2022

Hepatotoxicity, Tenosynovial Giant Cell Tumor Trial in United States (TURALIO™)

Recruiting
  • Hepatotoxicity
  • Tenosynovial Giant Cell Tumor
  • Santa Monica, California
  • +4 more
Jun 6, 2022

Tenosynovial Giant Cell Tumor Trial in Worldwide (Pexidartinib)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • Pexidartinib
  • Scottsdale, Arizona
  • +15 more
Apr 29, 2022

Moderate Hepatic Impairment Trial in Miami, Orlando (Pexidartinib)

Completed
Has Results
  • Moderate Hepatic Impairment
  • Pexidartinib
  • Miami, Florida
  • +1 more
Jun 11, 2021

Colorectal Cancer, Pancreatic Cancer, Metastatic Cancer Trial in Lyon, Toulouse (Pexidartinib, Durvalumab)

Completed
  • Colorectal Cancer
  • +3 more
  • Lyon, France
  • +1 more
Sep 2, 2021

Gastrointestinal Stromal Tumor (GIST) Trial in New York (MEK162, Pexidartinib)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 29, 2021

Drug Interaction Potential Trial in Worldwide (Tolbutamide, Midazolam, Pexidartinib)

Completed
Has Results
  • Drug Interaction Potential
  • Scottsdale, Arizona
  • +10 more
Apr 19, 2021

Melanoma Trial in Beijing, Guangzhou, Seoul (PLX3397)

Active, not recruiting
Has Results
  • Melanoma
  • Beijing, Beijing, China
  • +4 more
Apr 21, 2022

Gastrointestinal Stromal Tumors Trial in United States (PLX9486, Pexidartinib, Sunitinib)

Completed
  • Gastrointestinal Stromal Tumors
  • Miami, Florida
  • +5 more
Apr 30, 2021

Healthy Volunteers Trial in San Antonio (Treatment A - 400 mg Fasting, Treatment B - 400 mg Fed, Treatment C - 200 mg Fed)

Completed
Has Results
  • Healthy Volunteers
  • Treatment A - 400 mg Fasting
  • +2 more
  • San Antonio, Texas
    Worldwide Clinical Trials
Apr 22, 2020

Solid Tumors Trial in United States (PLX3397, Paclitaxel)

Completed
Has Results
  • Solid Tumors
  • Birmingham, Alabama
  • +7 more
Jul 14, 2020

Patients With Newly Diagnosed Glioblastoma Trial in United States (PLX3397, Radiation Therapy, Temozolomide)

Completed
Has Results
  • Patients With Newly Diagnosed Glioblastoma
  • Chicago, Illinois
  • +8 more
Jun 19, 2020

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
Has Results
  • Melanoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020

Pharmacokinetics in Healthy Volunteers Trial in San Antonio (Pexidartinib, Probenecid)

Completed
  • Pharmacokinetics in Healthy Volunteers
  • San Antonio, Texas
    Worldwide Clinical Trials Early Phase Services
May 1, 2017